The SECURITY ( Second Generation Drug-Eluting Stent Implantation Followed by Six - Versus Twelve-Month Dual Antiplatelet Therapy ) trial was a 1:1 randomized , multicenter , international , investigator-driven , noninferiority study conducted from July 2009 to June 2014 .